{
    "clinical_study": {
        "@rank": "163008", 
        "arm_group": {
            "arm_group_label": "Steroid Injection", 
            "description": "Reactions associated with spinal steroid injection"
        }, 
        "brief_summary": {
            "textblock": "Many systemic reactions occur commonly after spinal steroid injections, especially in\n      patients, and may be associated with underlying disease, such as hypertension and diabetes\n      mellitus, as well as steroid dose and repetition of spinal steroid injection."
        }, 
        "brief_title": "Incidence of Various Types of Systemic Reactions Related to Spinal Steroid Injection: A Prospective Study", 
        "completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "condition": "Incidence and Types of Systemic Reactions Occurring After Spinal Steroid Injection in a Large Population", 
        "detailed_description": {
            "textblock": "Evaluate the incidence and types of systemic reactions after spinal steroid injections and\n      to investigate the association of spinal steroid injection with patient demographics,\n      history of previous injections, type and dose of steroid, and method and site of previous\n      and current injections."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Indicaion of steroid injction.\n\n        Exclusion Criteria:\n\n          -  Contraindiation of steroid injction."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "94 Years", 
            "minimum_age": "13 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients receiving the injection were informed of the aim and protocol of this study\n        and the possible local and systemic reactions associated with spinal steroid injection"
            }
        }, 
        "enrollment": {
            "#text": "997", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01756196", 
            "org_study_id": "B-1008/016-004"
        }, 
        "intervention": {
            "arm_group_label": "Steroid Injection", 
            "description": "Steroid Injection", 
            "intervention_name": "Spinal Steroid Injection", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Spinal injection; Steroid; Systemic reaction; Complication; Side effect; Diabetes mellitus; Hypertension; Risk factor", 
        "lastchanged_date": "December 19, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoung Nam", 
                    "country": "Korea, Republic of", 
                    "state": "Bundang", 
                    "zip": "463-802"
                }, 
                "name": "Seoul National University Bundang Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Observational Study of Evaluate the Incidence and Types of Systemic Reactions After Spinal Steroid Injections", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Evaluation of episodes of systemic reactions after spinal steroid injection", 
            "measure": "episodes of systemic reactions after spinal steroid injection", 
            "safety_issue": "No", 
            "time_frame": "2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01756196"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Bundang Hospital", 
            "investigator_full_name": "Guen Young Lee", 
            "investigator_title": "Associate Professor, MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "49801", 
            "citation": "Goldstein G, Schlesinger DH. Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin. Lancet. 1975 Aug 9;2(7928):256-9."
        }, 
        "source": "Seoul National University Bundang Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Bundang Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Weeks", 
        "verification_date": "December 2012"
    }
}